What best means in this list
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
Companies belong to the Bioinformatics classification, based on company products and revenue. Classifications can overlap, so a company may appear in several industry lists.
Ratings and dated fundamentals
| 1 | Adaptive Biotechnologies Corporation Common Stock | ADPT | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $26.09 | $4,163,855,517.78 | Not reported | 27.64 |
| 2 | Caris Life Sciences, Inc. Common Stock | CAI | 2.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $27.5 | $7,771,367,615 | 73.92 | 13.13 |
| 3 | Certara, Inc. Common Stock | CERT | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.64 | $1,317,935,059.2 | Not reported | 1.36 |
| 4 | QIAGEN N.V. | QGEN | 2.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $44.53 | $9,195,222,350 | 21.64 | 2.43 |
| 5 | GeneDx Holdings Corp. Class A Common Stock | WGS | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $67.73 | $2,019,880,701.93 | Not reported | 8.27 |
| 6 | Bullfrog AI Holdings, Inc. Common Stock | BFRG | 1.5 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.69 | $12,838,239.15 | Not reported | 1.84 |
| 7 | Champions Oncology, Inc. | CSBR | 1.5 | 2025-12-16 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.98 | $69,314,473.62 | Not reported | 15.54 |
| 8 | MindWalk Holdings Corp. Common Stock | HYFT | 1.5 | 2025-12-15 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.43 | $67,369,685.24 | Not reported | 7.79 |
| 9 | Seer, Inc. Class A Common Stock | SEER | 1.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.17 | $120,157,272.55 | Not reported | 0.53 |
| 10 | Tempus AI, Inc. Class A Common Stock | TEM | 1.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $69.28 | $12,151,086,193.76 | Not reported | 27.31 |
| 11 | Bionano Genomics, Inc. Common Stock | BNGO | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.46 | $17,194,420 | Not reported | 0.54 |
No matching rows. Clear the filter to see all records.
11 companies with eligible ratings and dated fundamentals, from 13 eligible companies in this selection.
Dates and coverage
Report dates range from 2025-08-13 to 2025-12-31. Market observations range from 2026-10-08 to 2026-10-08. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 2 companies without a report, 0 with invalid latest rating metadata, 0 with older reports, 0 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.